
DBV Technologies S.A. DBVT
$ 21.71
0.46%
Quarterly report 2025-Q2
added 07-29-2025
DBV Technologies S.A. P/B Ratio 2011-2026 | DBVT
Annual P/B Ratio DBV Technologies S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23 | 0.584 | 0.553 | 0.885 | 0.738 | 2.96 | 2.79 | 7.45 | 6.66 | 3.18 | 5.57 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23 | 0.553 | 4.94 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
5.82 | $ 18.24 | -1.41 % | $ 2.68 B | ||
|
Amgen
AMGN
|
1.7 | $ 344.45 | 0.75 % | $ 185 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
4.51 | $ 73.14 | 5.5 % | $ 9.78 B | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Biogen
BIIB
|
1.16 | $ 178.43 | -0.81 % | $ 26 B | ||
|
Aytu BioScience
AYTU
|
0.127 | $ 2.7 | 3.85 % | $ 17 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
1.74 | $ 2.87 | 4.36 % | $ 162 M | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | ||
|
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.11 | -2.05 % | $ 7.48 B | ||
|
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | ||
|
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | ||
|
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | ||
|
Burford Capital Limited
BUR
|
1.26 | $ 9.77 | 0.83 % | $ 1.59 B | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
-8.4 | $ 1.39 | -1.42 % | $ 261 M | ||
|
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | ||
|
Ascendis Pharma A/S
ASND
|
8.34 | $ 222.86 | -1.43 % | $ 5 B | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 4.12 | 2.74 % | $ 8.96 B | ||
|
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 109.1 | -4.09 % | $ 27.2 B | ||
|
Athira Pharma
ATHA
|
0.36 | - | - | $ 269 M | ||
|
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | ||
|
Autolus Therapeutics plc
AUTL
|
0.991 | $ 1.39 | 1.09 % | $ 355 M | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | ||
|
Cardiff Oncology
CRDF
|
2.34 | $ 1.75 | -0.29 % | $ 83.4 M | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
Compugen Ltd.
CGEN
|
2.26 | $ 1.85 | 0.54 % | $ 166 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M | ||
|
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M | ||
|
Amneal Pharmaceuticals
AMRX
|
0.522 | $ 14.11 | 3.14 % | $ 4.36 B | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Atreca
BCEL
|
0.625 | - | -11.76 % | $ 5.79 M | ||
|
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
-3.61 | $ 6.64 | 0.91 % | $ 1.37 B | ||
|
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | ||
|
Beam Therapeutics
BEAM
|
3.41 | $ 27.95 | 1.19 % | $ 2.3 B | ||
|
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B |